What would be an appropriate suppressive therapy for a patient with genital herpes?

What would be an appropriate suppressive therapy for a patient with genital herpes?

• A. Acyclovir 400 mg by mouth daily
• B. Valacyclovir 500 mg by mouth daily for 1 year
• C. Famciclovir 250 mg by mouth twice a day
• D. Valacyclovir 1 g by mouth daily

Answer: (B)

In the context of suppressive therapy for genital herpes, selecting a regimen that effectively reduces the frequency of outbreaks and transmission risk is crucial. Valacyclovir 500 mg by mouth daily for 1 year is considered an appropriate choice because it has been shown to significantly decrease both the incidence of symptomatic recurrences and the probability of transmitting the virus to uninfected partners. Valacyclovir is a prodrug of acyclovir, which means that once ingested, it is converted into acyclovir in the body. This results in a more convenient dosing schedule and improved bioavailability compared to acyclovir. A daily dose of 500 mg helps maintain adequate levels of the antiviral medication in the system to effectively suppress viral replication and manage outbreaks over an extended period. The length of treatment for a year aligns with current clinical guidelines, which recommend long-term suppressive therapy in individuals with frequent recurrences or serious psychosocial stress related to outbreaks. By continuing treatment for this duration, patients can experience significant benefits in terms of both physical symptoms and quality of life, and they can lessen the risk of transmission to partners.

In the context of suppressive therapy for genital herpes, selecting a regimen that effectively reduces the frequency of outbreaks and transmission risk is crucial. Valacyclovir 500 mg by mouth daily for 1 year is considered an appropriate choice because it has been shown to significantly decrease both the incidence of symptomatic recurrences and the probability of transmitting the virus to uninfected partners.

Valacyclovir is a prodrug of acyclovir, which means that once ingested, it is converted into acyclovir in the body. This results in a more convenient dosing schedule and improved bioavailability compared to acyclovir. A daily dose of 500 mg helps maintain adequate levels of the antiviral medication in the system to effectively suppress viral replication and manage outbreaks over an extended period.

The length of treatment for a year aligns with current clinical guidelines, which recommend long-term suppressive therapy in individuals with frequent recurrences or serious psychosocial stress related to outbreaks. By continuing treatment for this duration, patients can experience significant benefits in terms of both physical symptoms and quality of life, and they can lessen the risk of transmission to partners.